Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Century Therapeutics, Inc. | Director | Stock Option (right to buy) | 44K | Jun 20, 2024 | Direct | ||
Olema Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 23K | Jun 14, 2024 | Direct | ||
UroGen Pharma Ltd. | Director | Stock Option (right ot buy) | 10K | Aug 6, 2024 | Direct |